Mitranovici, M. Et Al. 2023. Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature. Stresses , no.3 , 125-135.

Mitranovici, M., Chiorean, D. M., Muresan, M. C., Buicu, C., Moraru, R., Moraru, L., ... Cotoi , T. C.(2023). Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature. Stresses , no.3, 125-135.

Mitranovici, Melinda-Ildiko Et Al. "Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature," Stresses , no.3, 125-135, 2023

Mitranovici, Melinda-Ildiko Et Al. "Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature." Stresses , no.3, pp.125-135, 2023

Mitranovici, M. Et Al. (2023) . "Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature." Stresses , no.3, pp.125-135.

@article{article, author={Melinda-Ildiko Mitranovici Et Al. }, title={Treating Preeclampsia in the COVID-19 Era: Is Allopurinol Useful as an Adjuvant Therapy? A Case Report and Review of the Literature}, journal={Stresses}, year=2023, pages={125-135} }